Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study [PDF]
HASHIMOTO Naotake +10 more
core +2 more sources
Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus. [PDF]
Aloke C +4 more
europepmc +1 more source
Edible Yellow Mealworm-Derived Antidiabetic Peptides: Dual Modulation of α-Glucosidase and Dipeptidyl-Peptidase IV Inhibition Revealed by Integrated Proteomics, Bioassays, and Molecular Docking Analysis. [PDF]
Zhu Y, Zhou E, Tang Y, Li Q, Wu L.
europepmc +1 more source
Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis. [PDF]
Choi J +9 more
europepmc +1 more source
The dipeptidyl peptidase IV inhibitor NVP-DPP728 reduces plasma glucagon concentration in cats
Daniela Furrer +4 more
openalex +1 more source
Comparative Weight Change With Initiation and Adherence to Common Medications for Type 2 Diabetes. [PDF]
Sneed NM +10 more
europepmc +1 more source
Application of HPSEC Technique and In Silico Analysis in the Evaluation of Bioactive Peptides and Polysaccharide Profile in Wort Supplemented with Malted and Unmalted Hemp Seeds. [PDF]
Duliński R +4 more
europepmc +1 more source

